Home › Compare › NYWKF vs ABBV
NYWKF yields 305.34% · ABBV yields 3.06%● Live data
📍 NYWKF pulled ahead of the other in Year 1
Combined, NYWKF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NYWKF + ABBV for your $10,000?
NTG Clarity Networks Inc. provides telecommunications engineering, information technology, networking, and related software solutions worldwide. Its products include StageEM, an enterprise solution that covers project portfolio management, demand and capacity, analytic and dashboard, and decision-making using real-time data; Workflow Management solution, which enables organizations to design, deploy, execute, monitor, and analyze their business processes; Network Inventory Management solution that covers networks, services, and resources for organizations; and Partner Relationship Management solution, which covers the value chain of partnerships and enables vendors to manage their strategic partners. The company's products also include NTS Asset Management solution that tracks life-cycle of an inventory from acquisition to delivery to retirement; NTS Trouble Ticket Management, a module that manages customer and network trouble tickets and allows users to create their own type of trouble tickets; NTS Utility Billing solution, which manages utility billing needs; Mi-World, an m-Commerce application for mobile shopping; and Telco In A Box solution, a pre-integrated CRM, order management, fulfillment, and billing solution. In addition, the company offers VoWiFi, an app that enables voice in WiFi for smartphones and androids; Last Mile Delivery, a platform that manages delivery activities, such as order taking, fulfillment, and delivery; PROXBOX, an IoT solution that automates the update of inventory, manufacturing, and asset management over 3G cellular, WiFi, and ethernet; and end-to-end business solutions that enables business to be managed remotely through accessible dashboards. Further, it provides solution development, system integration, testing as a service, outsourcing, consulting, training, and smart cities/building services, as well as digital transformation and data migration services. The company was founded in 1992 and is based in Markham, Canada.
Full NYWKF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.